Clinical trials
Oncological Patients clinical trials
Below are recruiting oncological patients clinical trials, each written for real people, not researchers. We’re tracking 290 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07416513Recruiting
Digital tools for better cancer care
This study explores how digital tools (apps or websites) can help people affected by cancer, including patients, caregivers, and healthcare workers. If you are a current or past cancer patient, a caregiver, or an oncology professional, you may be able to join.
CaenAges 12 years+ - NCT06772441RecruitingPhase 2
AI-guided radiation and hormone therapy for high-risk prostate cancer
This trial uses artificial intelligence to customize your radiation therapy and hormone treatment for high-risk prostate cancer. It aims to improve treatment precision and reduce side effects.
LimassolAges 18 years+ - NCT06647953RecruitingPhase 3
Testing a standard approach for pleuropulmonary blastoma, with or without topotecan
This trial compares a standard surgery and chemotherapy plan for type I pleuropulmonary blastoma (PPB) to adding the drug topotecan for types II and III PPB. The goal is to see if the extra drug helps shrink tumors and improve outcomes for children with more advanced disease.
Birmingham, AlabamaAges Up to 21 years - NCT06553612Recruiting
Supportive care planning after gynecological cancer treatment
This study compares a special day-hospital visit focused on supportive care needs to standard follow-up for people who have finished initial treatment for ovarian or endometrial cancer. The goal is to see if the special visit helps more people get the supportive care they need.
BesançonAges 18 years+ - NCT04953910RecruitingPhase 1
Oral decitabine for cancers with liver problems
This Phase 1 trial studies how a pill form of decitabine/cedazuridine behaves in the body and how safe it is for people whose livers don’t work normally. It may help doctors better understand dosing and safety in patients with hepatic impairment.
Houston, TexasAges 18 years+ - NCT04953897RecruitingPhase 1
Oral decitabine for cancer patients with kidney problems
This Phase 1 trial studies how an oral combination cancer medicine behaves in the body (dose handling and safety) in people with kidney impairment. It may help doctors learn the safest way to use this treatment when kidney function is reduced.
Houston, TexasAges 18 years+ - NCT04985058Recruiting
Study of abemaciclib plus hormone therapy in breast cancer
This study uses real-world health records to learn about outcomes in people with hormone-receptor positive, HER2-negative breast cancer who were treated with abemaciclib along with hormone (endocrine) therapy. It may help doctors better understand how well this treatment works outside of clinical trials.
AthensAges 18 years+ - NCT04988009Recruiting
Telemedicine care experience survey for brain tumor patients
This trial asks brain tumor patients and caregivers to share what they think about the quality of care they receive through telemedicine. Your feedback may help improve how neuro-oncology visits are done by video in the future.
Houston, TexasAges 18 years+ - NCT05909436RecruitingPhase 1/Phase 2
Study GLS-012 for advanced solid tumors
This trial tests an immunotherapy drug called GLS-012, alone and with another drug (GLS-010), in people with advanced solid cancers that have worsened despite standard treatment. It aims to see how well the treatment works and how safe it is, especially when given in different combinations.
BeijingAges 18–75 - NCT06187870Recruiting
Biobank for urological and cancer research
This study collects blood, urine, and tissue samples from patients with urological diseases or cancers to build a biobank for future research. It may help researchers better understand these conditions and develop new treatments.
Milan, LombardyAges 18 years+ - NCT06590766Recruiting
Acupuncture and massage for cancer patients in and after hospital
This trial studies whether adding acupuncture and hands-on therapies to standard care can improve quality of life for cancer patients. It starts in the hospital and continues as you transition back home.
Haifa, IsraelAges 18–100 - NCT06060990Recruiting
Copper and trace elements in biliary tract cancer
This study looks at levels of copper and other minerals in the blood of people with biliary tract cancer (cancer of the bile ducts or gallbladder). If you have not had treatment yet, this trial may help doctors understand how these elements relate to your cancer.
LjubljanaAges 18–80 - NCT05945121Recruiting
Exercise and coaching program to protect heart in stem cell transplant
This trial tests a pre-transplant exercise and training program to improve heart “reserve,” or how well your heart handles stress, in people at higher heart risk. If you qualify, you may be asked to use a heart-rate tracking app during the program before your stem cell transplant.
Ann Arbor, MichiganAges 18 years+ - NCT07501663Recruiting
Managing nerve damage from chemo in GI cancer survivors
This study tests different integrative approaches (like acupuncture or supplements) to help GI cancer survivors manage nerve damage from chemotherapy. You may be able to join if you have ongoing numbness and tingling from chemo.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07399821RecruitingPhase 1/Phase 2
Imaging study of anti-GD2-800CW in neuroblastoma
This trial tests a special dye (anti-GD2-800CW) that lights up neuroblastoma cells during surgery, helping surgeons see and remove more of the tumor. It is for children with neuroblastoma who are scheduled to have surgery.
UtrechtAges 1–18 - NCT07180693Recruiting
Breast cancer that returns after CDK4/6 inhibitor treatment
This study looks at patients whose breast cancer returns after starting a CDK4/6 inhibitor (like abemaciclib or ribociclib) along with hormone therapy. The goal is to understand why the cancer comes back and find better ways to treat it.
Bergamo, ItalyAges 18 years+ - NCT07175350Recruiting
Cost of cancer radiation therapy in Italy
This study looks at how the cost of radiation therapy affects cancer patients in Italy. It aims to understand the financial burden and find ways to help.
BarlettaAges 18 years+ - NCT07066917Recruiting
Breast cancer treatment response study
This study looks at how well newer treatments work for advanced or metastatic breast cancer and why some people respond better than others. It is for anyone with HR-positive, HER2-positive/low, or triple-negative breast cancer who has started at least one treatment cycle.
AthensAges 18 years+ - NCT04962711Recruiting
Risk-guided plan to prevent heart failure after cancer treatment
This trial tests whether a personalized, risk-based heart care plan can help prevent heart failure in people who had certain cancer treatments. It focuses on monitoring and guiding treatment, using heart ultrasound results and other health factors.
Melbourne, VictoriaAges 40–85 - NCT04935853Recruiting
Study of markers that predict bile duct cancer treatment response
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
AmiensAges 18 years+ - NCT06771336Recruiting
Study of standard care for jawbone reconstruction after cancer
This trial studies current standard care for people who need jawbone reconstruction after cancer surgery. It aims to document the costs and outcomes of using a piece of bone from another part of the body (a free bone flap) to rebuild the face.
AmiensAges 18 years+ - NCT06344208Recruiting
Predicting side effects in older adults with head and neck cancer
This trial studies how to predict side effects (toxicity) in older adults (70+) with advanced head and neck cancer. It tests standard treatments like radiation, chemoradiation, or radiation with cetuximab and aims to help doctors tailor care to reduce harm.
Milan, MilanAges 70–99 - NCT04268849RecruitingPhase 3
IV vs oral iron after weight-loss surgery
This Phase 3 study compares taking iron through an IV versus by mouth to treat iron-deficiency anemia after Roux-en-Y gastric bypass or sleeve gastrectomy. The goal is to see which method works better and is safer for improving iron levels and blood counts.
Baltimore, MarylandAges 18 years+ - NCT05866458Recruiting
Radiation after lumpectomy for node-negative breast cancer
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
Cudgen, CudgenAges 50 years+
Hear when a new Oncological Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for oncological patients?
- Yes. Clin2 currently lists 290 recruiting oncological patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a oncological patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a oncological patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.